+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Resynchronisation Therapy (CRT) - Medical Devices Pipeline Assessment, 2019

  • PDF Icon

    Report

  • 90 Pages
  • December 2019
  • Region: Global
  • GlobalData
  • ID: 4898180
Description Jump to:
Cardiac Resynchronisation Therapy (CRT) - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Cardiac Resynchronisation Therapy (CRT) - Medical Devices Pipeline Assessment, 2019“ provides an overview of Cardiac Resynchronisation Therapy (CRT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Resynchronisation Therapy (CRT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiac Resynchronisation Therapy (CRT) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Resynchronisation Therapy (CRT) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Resynchronisation Therapy (CRT) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Introduction
1.1 Cardiac Resynchronisation Therapy (CRT) Overview
2 Products under Development
2.1 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
2.2 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment
2.3 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
2.4 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
2.5 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
2.6 Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials
3 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products under Development by Companies
3.1 Cardiac Resynchronisation Therapy (CRT) Companies - Pipeline Products by Stage of Development
3.2 Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
4 Cardiac Resynchronisation Therapy (CRT) Companies and Product Overview
4.1 Boston Scientific Corp Company Overview
4.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
4.2 DHS Medical Company Overview
4.2.1 DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
4.3 EBR Systems Inc Company Overview
4.3.1 EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
4.4 IRadimed Corp Company Overview
4.4.1 IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
4.5 Johns Hopkins University Company Overview
4.5.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
4.6 Mayo Clinic Company Overview
4.6.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
4.7 Medtronic plc Company Overview
4.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
4.8 MicroPort CRM Company Overview
4.8.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
4.9 NewPace Ltd Company Overview
4.9.1 NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.10 Odem Medical Ltd Company Overview
4.10.1 Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5 Cardiac Resynchronisation Therapy (CRT)- Recent Developments
5.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
5.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
5.3 Oct 30, 2019: LivaNova reports third quarter 2019 results
5.4 Oct 23, 2019: Boston Scientific announces results for third quarter 2019
5.5 Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes
6 Appendix
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
Table 2: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment
Table 3: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
Table 4: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
Table 5: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
Table 6: Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials
Table 7: Cardiac Resynchronisation Therapy (CRT) Companies - Pipeline Products by Stage of Development
Table 8: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
Table 9: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Next Generation Quad Polar CRT-D - Product Status
Table 11: Next Generation Quad Polar CRT-D - Product Description
Table 12: NG3 Non Quad System - Product Status
Table 13: NG3 Non Quad System - Product Description
Table 14: Resonate 2.0 - Product Status
Table 15: Resonate 2.0 - Product Description
Table 16: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 17: Next Generation Quad Polar CRT-D - Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan
Table 18: DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Drimmer - Product Status
Table 20: Drimmer - Product Description
Table 21: Twistek - Product Status
Table 22: Twistek - Product Description
Table 23: EBR Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Second Generation WiSE CRT System - Product Status
Table 25: Second Generation WiSE CRT System - Product Description
Table 26: WiSE CRT System - Product Status
Table 27: WiSE CRT System - Product Description
Table 28: EBR Systems Inc - Ongoing Clinical Trials Overview
Table 29: WiSE CRT System - Image Optimization and Guidance for Wireless Endocardial Cardiac Resynchronization Therapy: The CT Guided Trial
Table 30: WiSE CRT System - Multicenter, Prospective Evaluation of Safety and Performance of the WiCS-LV System in Patients Indicated for Cardiac Resynchronization Therapy
Table 31: WiSE CRT System - Stimulation of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-responders and Previously Untreatable Patients (SOLVE CRT)
Table 32: IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 33: MR Defibrillator - Product Status
Table 34: MR Defibrillator - Product Description
Table 35: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Cardiac Arrhythmia Termination Device - Product Status
Table 37: Cardiac Arrhythmia Termination Device - Product Description
Table 38: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Atrial Fibrillation Device - Product Status
Table 40: Atrial Fibrillation Device - Product Description
Table 41: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: MRI Safe CRT-D - Product Status
Table 43: MRI Safe CRT-D - Product Description
Table 44: Next Gen ICD And CRT-D - Product Status
Table 45: Next Gen ICD And CRT-D - Product Description
Table 46: MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
Table 47: PARADYM RF SonR CRT-D - Product Status
Table 48: PARADYM RF SonR CRT-D - Product Description
Table 49: Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Status
Table 50: Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Description
Table 51: NewPace Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 52: The Implantable Subcutaneous String Defibrillator (ISSD) - Product Status
Table 53: The Implantable Subcutaneous String Defibrillator (ISSD) - Product Description
Table 54: Odem Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Odem Device - Product Status
Table 56: Odem Device - Product Description
Table 57: Glossary
List of Figures
Figure 1: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Stage of Development
Figure 2: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Segment
Figure 3: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Territory
Figure 4: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Regulatory Path
Figure 5: Cardiac Resynchronisation Therapy (CRT) - Pipeline Products by Estimated Approval Date
Figure 6: Cardiac Resynchronisation Therapy (CRT) - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Boston Scientific Corp
  • DHS Medical
  • EBR Systems Inc
  • IRadimed Corp
  • Johns Hopkins University
  • Mayo Clinic
  • Medtronic plc
  • MicroPort CRM
  • NewPace Ltd
  • Odem Medical Ltd

Related Topics

Related Reports

Cardiac Resynchronisation Therapy (CRT) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 - Product Image

Cardiac Resynchronisation Therapy (CRT) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

  • Report
  • Global
From
Cardiac Resynchronisation Therapy Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 - Product Image

Cardiac Resynchronisation Therapy Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033

  • Report
  • Global
From
Cardiac Rhythm Management (CRM) Devices: Global Strategic Business Report - Product Image

Cardiac Rhythm Management (CRM) Devices: Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Cardiac Resynchronization Therapy (CRT) Devices - Global Strategic Business Report - Product Image

Cardiac Resynchronization Therapy (CRT) Devices - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Global Leadless Pacemakers Market Size, Share & Industry Trends Analysis Report By Type (Micra Transcatheter Pacing System, and Others), By End-use (Hospitals, and Outpatient Facilities), By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Leadless Pacemakers Market Size, Share & Industry Trends Analysis Report By Type (Micra Transcatheter Pacing System, and Others), By End-use (Hospitals, and Outpatient Facilities), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.